Dr. Michael Silva Performs First Percutaneous Transmural Arterial Bypass in Galveston

On Thursday, Dr. Michael Silva, a vascular surgeon at the University of Texas Medical Branch (UTMB), achieved a significant milestone by performing the first Percutaneous Transmural Arterial Bypass in the region using the innovative Detour system. Last year, the U.S. Food and Drug Administration (FDA) approved this innovative procedure, which provides a minimally invasive alternative to conventional bypass surgery.

The Detour system is intended to treat patients with complex vascular conditions, offering a novel treatment option for those who may not be suitable candidates for traditional surgical procedures. Dr. Silva's successful operation represents a substantial advancement in the field of vascular surgery, which has the potential to enhance patient outcomes and recovery dates.

‍

Dr. Silva conveyed his enthusiasm for the new technology in a statement released after the procedure. "This technique enables us to bypass blocked arteries without the necessity of large incisions, thereby significantly reducing the recovery time and associated risks," he stated. "We are thrilled to provide this alternative to our patients in the Texas region."

‍

The procedure entails the establishment of a bypass route with a catheter, which expedites the healing process and reduces the amount of trauma to the adjacent tissues. UTMB is positioned as a leader in innovative medical remedies due to Dr. Silva's expertise in vascular surgery and this state-of-the-art technology.

‍

The Detour system can potentially change how vascular issues are treated by providing patients with less invasive options and better overall care as more healthcare facilities implement similar techniques. Dr. Silva's innovative work improves surgical practices and establishes a standard for future advancements in medical technology in the region.

‍